Clinical Trials
47 trialsPIRe
Rigshospitalet, Denmark
EViDENCE-BT
University of Zurich
MRinRT
Swansea Bay University Health Board
rTMS for Postoperative Brain Tumor Patients
Columbia University
A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors(CROWN)
Tianjin Medical University Cancer Institute and Hospital
Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)
Beijing Tiantan Hospital
Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma
Wake Forest University Health Sciences
Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors
Thomas Jefferson University
LOC-R01
Institut Curie
GK-LIVE
Sunnybrook Health Sciences Centre
A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data
Xiangya Hospital of Central South University
Carboplatin and Bevacizumab for Recurrent Ependymoma
National Institutes of Health Clinical Center (CC)
STRATUM-OS
Fundación Canaria de Investigación Sanitaria
STRONGER
The George Institute
MILANO
Centre Hospitalier Universitaire de Saint Etienne
Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors
Suzhou Maximum Bio-tech Co., Ltd.
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Virginia Commonwealth University
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Stanford University
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
H. Lee Moffitt Cancer Center and Research Institute
METAMORF
University of Aarhus
MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning
Memorial Sloan Kettering Cancer Center
Dietary Patterns and Health Outcomes (Cardiovascular, Metabolic, Endocrine, Neurological, Skeletal Muscular, Cancer)
Harvard School of Public Health (HSPH)
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
Wake Forest University Health Sciences
ESIBAC
Hull University Teaching Hospitals NHS Trust
Tx-Treatment
Stanford University
PIONEER
SpeciCare
Refining and Testing the Electronic Social Network Assessment Program (eSNAP)
H. Lee Moffitt Cancer Center and Research Institute
NCGENES
University of North Carolina, Chapel Hill
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
H. Lee Moffitt Cancer Center and Research Institute
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Stanford University
Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors
Virginia Commonwealth University
B-Receptor Signaling in Cardiomyopathy
Stanford University
Virtual Reality-Based Exercise in Cancer Patients
University of Arizona
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
FDA Office of Orphan Products Development
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
FDA Office of Orphan Products Development
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
FDA Office of Orphan Products Development
Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery
Assaf-Harofeh Medical Center
Depocyt® With Sorafenib in Neoplastic Meningitis
H. Lee Moffitt Cancer Center and Research Institute
A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
Stanford University
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
University of New Mexico
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
National Center for Research Resources (NCRR)
Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and Adolescents
National Center for Research Resources (NCRR)
Study of the Neurobiology of Tourette Syndrome and Related Disorders
National Center for Research Resources (NCRR)
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Office of Rare Diseases (ORD)